| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V117308 | (D-Pro7)-Angiotensin I/II (1-7) | 586962-44-9 | (D-Pro7)-angiotensin I/II (1-7) is a selective peptide angiotensin-(1-7) antagonist. |
|
V122046 | (Rac)-Valsartan-d9 | (Rac)-Valsartan-d9 is a deuterated valsartan. | |
|
V103135 | 15-Keto-PGA1 | 61600-67-7 | 15-Keto-PGA1 is a metabolite of PGA1 and has a significant vasoconstrictive effect. |
|
V77338 | [Sar1, Ile8]-Angiotensin II TFA (AngiotensinII TFA; Angiotensin 2 TFA) | [Sar1, Ile8]-Angiotensin II (TFA) is a polypeptide that has multiple effects in vascular smooth muscle cells such as contraction of normal arteries, hypertrophy or proliferation of cultured cells or diseased blood vessels, etc. | |
|
V127996 | AAA | AAA is an orally effective 20-HETE receptor antagonist. | |
|
V77260 | Angiotensin I/II (1-6) (TFA) | Angiotensin I/II (1-6) TFA contains 1-6 amino acid (AA)s and is converted from angiotensin I/II peptide. | |
|
V105228 | AT2R-IN-1 | 2896132-06-0 | AT2R-IN-1 (A-174) is an inhibitor of AT2R and can be used for neuropathic pain research. |
|
V75289 | Azilsartan mepixetil potassium (QR-01019K) | 2153458-32-1 | Azilsartan mepixetil potassium (QR-01019K) is an angiotensin II receptor antagonist. |
|
V4098 | CGP-42112 | 127060-75-7 | CGP-42112(also known as CGP-42112A) is a novel, potent and selective Angiotensin-II subtype 2 receptor(AT2 R) agonist. |
|
V133130 | Cytosporin C | 175521-92-3 | Cytosporin C is a hexahydrobenzopyran derivative and an angiotensin II receptor inhibitor. |
|
V115480 | GA-0056 | 153465-66-8 | GA-0056 is an angiotensin II receptor blocker. |
|
V76753 | Mopivabil | 2988562-84-9 | Mopivabil is an angiotensin II receptor blocker (antagonist). |
|
V11930 | AVE-0991 sodium | 306288-04-0 | AVE0991 sodium, the sodium salt ofAVE-0991, is a novel, orally bioactivenon-peptide mimic and high affinity agonist of angiotensin-(1-7) with an IC50 of 21 nM. |
|
V75286 | Novokinin TFA | 1262750-59-3 | Novokinin TFA is a bioactive peptide agonist of the angiotensin AT2 receptor. |
|
V75297 | Olmesartan impurity | 154709-18-9 | Olmesartan impurity is the impurity of Olmesartan. |
|
V2884 | PD-123319 TFA salt | 136676-91-0 | PD 123319 ditrifluoroacetate is a novel, potent, and selective nonpeptide AT2 (angiotensin II) receptor antagonist with IC50 of 34 nM. |
|
V147341 | Zilebesiran sodium scrambled negative control | The Zilebesiran sodium scrambled negative control is a negative control with the sequence of Zilebesiran sodium scrambled. | |
|
V19995 | Eprosartan (SKF-108566J) | 133040-01-4 | Eprosartan (formerly SKF-108566J; SKF108566; SKF 108566; Teveten; Futuran; Navixen; Regulaten) is a nonpeptide angiotensin II receptor antagonist that has been approved as an antihypertensive medication for the treatment of high blood pressure. |
|
V5109 | Olmesartan (RNH-6270; CS-866) | 144689-24-7 | Olmesartan (formerly also known as CS-866) is a potent and selective angiotensin II type 1 (AT(1)) receptor antagonist used in the treatment of high blood pressure. |
|
V24404 | Losartan (DUP 89) | 114798-26-4 | Losartan (DuP-753) is a potent, selective, and non-peptide angiotensin II receptor antagonist, it competes with angiotensin II for bindingto AT1 receptors with IC50 of 20 nM. |